Int Wound J. 2025 Apr;22(4):e70522. doi: 10.1111/iwj.70522.
Y. Li, Z. Mei, L. Shi, Y. Wan, X. Zhou, T. Zeng, Y. Liu, J. Y. Yang, and Z. Shi, "Evaluation of Bevacizumab Biosimilar on Wound Healing Complications in Patients with Colorectal Cancer Undergoing Endoscopic Mucosal Resection: A Systematic Review and Meta-Analysis in Anorectal Medicine," International Wound Journal 21, no. 1 (2024): e14638, https://doi.org/10.1111/iwj.14638. The above article, published online on 23 January 2024, in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor in Chief, Professor Keith Harding; and John Wiley & Sons Ltd. Following an investigation by the publisher, all parties have concluded that this article was accepted solely on the basis of a compromised peer review process. The editors have therefore decided to retract the article. The authors did not respond to our notice regarding the retraction.
李阳、梅珍、施磊、万宇、周霞、曾涛、刘阳、杨静怡、施政，“贝伐单抗生物类似药对接受内镜黏膜切除术的结直肠癌患者伤口愈合并发症的评估：肛肠医学的系统评价和荟萃分析”，《国际伤口杂志》21卷，第1期（2024年）：e14638，https://doi.org/10.1111/iwj.14638 。上述文章于2024年1月23日在线发表于威利在线图书馆（http://onlinelibrary.wiley.com/），已根据期刊主编基思·哈丁教授与约翰·威利父子有限公司的协议撤回。经过出版商调查，各方得出结论，该文章仅基于有缺陷的同行评审过程被接受。因此，编辑们决定撤回该文章。作者未对我们关于撤回的通知做出回应。
